Industry Update: Pharmaceuticals

VRC just released it’s latest Industry Update on Pharmaceuticals! Read more for relevant market data, trends in EBITDA multiples, notable deals and more.

Industry Update: Specialty Chemicals

Read VRC’s latest Industry Update on Specialty Chemicals for relevant market data, trends in EBITDA multiples, notable deals and more.

Industry Update: Technology

VRC’s latest Industry Update on Technology was just released! Take a look to learn about relevant trends in EBITDA, market data, multiples, notable deals and more.

Valuation in Times of Uncertainty

Webcast Replay: What valuation impacts are companies feeling as a result of the market and economic disruptions created by the COVID-19 pandemic?

Recent Engagements: Fairness & Solvency Opinions

VRC is proud to share a list of recently completed fairness & solvency opinion engagements and thank our clients for allowing us to serve their needs.

2019 in Review: Private Equity

Takeaways and observations from private equity market activity in 2019.

US Private Equity

Summary of key Q3 2019 metrics for the PE deal environment, including median PE buyout EV/EBITDA multiples.

Industry Update: Building Products

Just released! Read VRC’s latest Industry Update on Building Products for relevant market data, trends in EBITDA multiples, notable deals and more.

Valuation Issues in the U.S.

Valuations in the U.S. are generally required around a transaction and can be grouped by needs for financial reporting, tax, or legal purposes, as well as for compliance or recurring regulatory purposes outside of a transaction.

Valuation Issues in Argentina

Argentina has five main valuation practice characteristics that companies must remain mindful of during the decision-making process when pursuing business transactions in the country.